Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Physiomics ( (GB:PYC) ) is now available.
Physiomics plc announced a change in its registered office location to Milton Park Innovation Centre, effective from 1 October 2025. This move reflects the company’s ongoing commitment to innovation and growth within the biotech and pharmaceutical industry, potentially enhancing its operational capabilities and industry positioning.
Spark’s Take on GB:PYC Stock
According to Spark, TipRanks’ AI Analyst, GB:PYC is a Underperform.
Physiomics’ stock score is primarily impacted by significant financial instability, including declining revenues and negative profit margins. Technical indicators reinforce a bearish outlook. While recent corporate events suggest potential growth pathways, current valuation issues and financial challenges remain significant obstacles.
To see Spark’s full report on GB:PYC stock, click here.
More about Physiomics
Physiomics plc is a leading company in the field of mathematical modelling, data science, and biostatistics, focusing on supporting the development of new therapeutics and personalized medicine solutions. The company aids biotech and pharma firms in streamlining drug development through expertise in Modelling & Simulation, Biostatistics, Data Science, and Bioinformatics, utilizing cutting-edge computational tools and proprietary technology to optimize research design.
Average Trading Volume: 3,201,376
Technical Sentiment Signal: Sell
Current Market Cap: £1.46M
For an in-depth examination of PYC stock, go to TipRanks’ Overview page.